These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8609244)
1. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis. Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244 [TBL] [Abstract][Full Text] [Related]
2. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
4. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667 [TBL] [Abstract][Full Text] [Related]
5. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991 [TBL] [Abstract][Full Text] [Related]
6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [TBL] [Abstract][Full Text] [Related]
7. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells. Tong FK; Chow S; Hedley D Cytometry B Clin Cytom; 2006 May; 70(3):107-14. PubMed ID: 16498671 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome. Hamaguchi H; Inokuchi K; Nara N; Nagata K; Yamamoto K; Yagasaki F; Dan K Int J Hematol; 1998 Feb; 67(2):153-64. PubMed ID: 9631582 [TBL] [Abstract][Full Text] [Related]
10. Transformation of myelodysplastic syndromes into acute myeloid leukemias. Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365 [TBL] [Abstract][Full Text] [Related]
11. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes]. Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564 [TBL] [Abstract][Full Text] [Related]
12. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells. Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262 [TBL] [Abstract][Full Text] [Related]
14. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. Orazi A; Kahsai M; John K; Neiman RS Mod Pathol; 1996 Jan; 9(1):48-52. PubMed ID: 8821956 [TBL] [Abstract][Full Text] [Related]
15. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes. Maratheftis CI; Bolaraki PE; Voulgarelis M Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514 [TBL] [Abstract][Full Text] [Related]
16. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373 [TBL] [Abstract][Full Text] [Related]